Innophos Holdings, Inc. (IPHS) Given Average Recommendation of “Buy” by Brokerages

Innophos Holdings, Inc. (NASDAQ:IPHS) has received a consensus broker rating score of 2.00 (Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a hold rating and one has assigned a strong buy rating to the company.

Zacks has also assigned Innophos Holdings an industry rank of 82 out of 265 based on the ratings given to its competitors.

A number of equities analysts recently issued reports on the stock. Zacks Investment Research raised shares of Innophos Holdings from a “hold” rating to a “strong-buy” rating and set a $54.00 target price on the stock in a research report on Tuesday, August 8th. KeyCorp reaffirmed a “hold” rating on shares of Innophos Holdings in a research report on Wednesday, November 1st.

Shares of Innophos Holdings (IPHS) traded up $0.26 during trading on Friday, hitting $44.65. 146,500 shares of the stock were exchanged, compared to its average volume of 114,967. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.86 and a quick ratio of 1.49. Innophos Holdings has a twelve month low of $41.66 and a twelve month high of $58.22. The firm has a market capitalization of $866.89, a PE ratio of 18.05 and a beta of 0.88.

Innophos Holdings (NASDAQ:IPHS) last issued its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.72 by $0.06. Innophos Holdings had a net margin of 6.19% and a return on equity of 13.90%. The business had revenue of $184.00 million during the quarter, compared to analysts’ expectations of $179.33 million. During the same period in the previous year, the company earned $0.69 earnings per share. Innophos Holdings’s revenue for the quarter was down 1.1% on a year-over-year basis. equities research analysts anticipate that Innophos Holdings will post 2.5 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 6th. Investors of record on Friday, November 17th will be given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 4.30%. The ex-dividend date of this dividend is Thursday, November 16th. Innophos Holdings’s dividend payout ratio (DPR) is currently 88.48%.

ILLEGAL ACTIVITY NOTICE: “Innophos Holdings, Inc. (IPHS) Given Average Recommendation of “Buy” by Brokerages” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2017/12/08/innophos-holdings-inc-iphs-given-average-recommendation-of-buy-by-brokerages.html.

Hedge funds have recently made changes to their positions in the stock. Old Mutual Global Investors UK Ltd. bought a new position in Innophos Holdings during the third quarter worth $109,000. Public Employees Retirement System of Ohio increased its position in Innophos Holdings by 5.9% during the second quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock worth $124,000 after acquiring an additional 157 shares during the period. Macquarie Group Ltd. bought a new position in Innophos Holdings during the third quarter worth $193,000. Piedmont Investment Advisors LLC bought a new position in Innophos Holdings during the third quarter worth $209,000. Finally, Pacad Investment Ltd. increased its position in Innophos Holdings by 19.5% during the second quarter. Pacad Investment Ltd. now owns 4,900 shares of the specialty chemicals company’s stock worth $215,000 after acquiring an additional 800 shares during the period. 94.81% of the stock is currently owned by institutional investors and hedge funds.

Innophos Holdings Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Get a free copy of the Zacks research report on Innophos Holdings (IPHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply